Health Care & Life Sciences » Biotechnology | Intellect Neurosciences Inc.

Intellect Neurosciences Inc.

Intellect Neurosciences Inc.
Stock Exchange Other OTC
EPS
$1.8
Market Cap
$273.84 K
Shares Outstanding
6.52 M
Public Float
-

Profile

Address
550 Sylvan Avenue
Englewood Cliffs New Jersey 07632
United States
Employees -
Website http://www.intellectns.com
Updated 09/14/2018
Intellect Neurosciences, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of neurodegenerative conditions, collectively known as proteinopathies, which include alzheimer's, parkinson's and huntington disease. The company was founded by Daniel G. Chain on April 25, 2005 and is headquartered in Englewood Cliffs, NJ.

Financials

View All

Elliot M. Maza
Chairman, Chief Executive & Financial Officer
Isaac Onn
Independent Director